📋 Today's Insider Activity — 3 filings

$QTEX — Parnes Tal, Director (BUY, $10K)
$FLSC — FHMLSP, L.L.C., Chief Executive Officer (BUY, $3.0M)
$NRIX — Hansen Gwenn, Chief Scientific Officer (SELL, $36K)

📈 Search any ticker → https://www.formdelta.com

#InsiderTrading #StockMarket

I looked at the business behind $NRIX (Nurix Therapeutics, Inc.) for you. Based on financial data and reported results.

At what market price would buying or selling $NRIX make sense to you?

#NRIX #Nurix

#NRIX Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

https://www.stocktitan.net/news/NRIX/nurix-therapeutics-reports-third-quarter-2026-financial-results-and-n5zklsk1p6gt.html?utm_source=stocktitan-bluesky&utm_medium=social

#NRIX Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

https://www.stocktitan.net/news/NRIX/nurix-therapeutics-announces-second-research-term-extension-for-zq5bb9a9yq9w.html?utm_source=stocktitan-bluesky&utm_medium=social

🔴 $NRIX — Ring Christine, Chief Legal Officer
SOLD: 5,786 shares @ $23.19
Total: $134K
Filed Oct 1, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/NRIX

#InsiderTrading #NRIX #StockMarket

#NRIX Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer

https://www.stocktitan.net/news/NRIX/nurix-therapeutics-announces-achievement-of-7-million-milestone-3r1bguu6gyyk.html?utm_source=stocktitan-bluesky&utm_medium=social